Cardiovascular risk management in antiphospholipid syndrome: trends over time and comparison with rheumatoid arthritis and diabetes mellitus

OBJECTIVE: Antiphospholipid syndrome (APS) is characterised by increased cardiovascular morbidity and mortality, related to thrombo-inflammatory and atherogenic mechanisms. We examined the achievement of traditional cardiovascular risk factor (CVRF) therapeutic goals in APS versus other high cardiov...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolla, Eleana, Tentolouris, Nikolas, Sfikakis, Petros P, Tektonidou, Maria G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Epidemiology and Outcomes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685967/
https://www.ncbi.nlm.nih.gov/pubmed/34921093
http://dx.doi.org/10.1136/lupus-2021-000579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685967/
https://www.ncbi.nlm.nih.gov/pubmed/34921093
http://dx.doi.org/10.1136/lupus-2021-000579

Ejemplares similares